PDF Print E-mail
Marketing Plan

In Negotiations

USA Drug
CVS Caremark
Patterson Medical
Sammons Preston
FootSmart Retailer
Box Butte Hospital
Methodist Hospital
Cardinal Hill Rehab
Mercer County Rehab

North America Dealers

Canada
AZ, OK, GA, MO, NE, KS, FL,
MN, TN, IA, WI, IL, MI, IN, OH,
KY, PA, VA, WV, TX

International Dealers

Portugal
Spain
Australia

Projected Revenue:
(above listed entities)

$414,396.00 per month
OR
$4,972,752.00 annually
The Company's initial sales and marketing efforts will focus on the promotion of the Shoe & Boot Valet™ among key business executives within the pharmaceutical, biotech, medical device and CRO industry with the initial and primary emphasis on large retail and pharmaceutical organizations.  Many of these contacts have already been established and will set the stage for the full and anticipated release of the Sock Valet in the fourth quarter 2010. 

Nine Industries have been identified and are being actively pursued for maximum distribution of product.

 Wholesalers: Health Care Food and Drug Stores
 McKesson  CVS Caremark
 Cardinal Health  Kroger
 AmerisourceBergen  Walgreen
 Owens & Minor  Safeway
 Henry Schein  Supervalu
 Patterson  Rite Aid
 PSS World Medical  Publix Super Markets
 Healthcare: Medical Facilities Medical Products & Equipment
 HCA  Medtronic
 Community Health Systems  Baxter International
 Tenet Healthcare  Boston Scientific
 DaVita  Becton Dickinson
 Universal Health Services Stryker
 Health Management Assoc. St. Jude Medical
 Kindred Healthcare Zimmer Holdings
 Vanguard Health Systems  Hill-Rom Holdings
 LitePoint Hospitals Invacare
 Magellan Health Services  Apria Healthcare
 Select Medical Holdings  General Merchandisers
 HealthSouth  Wal-Mart Stores
 KaiserPermanente  Target
US Government USA Dealer Network
 Department of Veteran Affairs  19 States & Growing
 Department of Health and Human Services  Puerto Rico
World Wide Web INT'L Dealer Network
 Footsmart  Canada
 Disaboom  Portugal
   Spain
  Australia

CRO (Clinical Research Organizations) Industry at a Glance
  • CROs provide product development services to the pharmaceutical, biotechnology, and medical-device industries, allowing their clients to manage product-development efforts more efficiently and cost-effectively.
  • The CRO market size is estimated at $17.8 billion and growing. Revenue is increasing at an annual rate of 14 - 16 percent.
  • According to an independent analyst, clinical trials conducted by CROs are completed an average of 30 percent more quickly than those conducted in-house. This results in an average time savings of some four to five months, translating to $120 million to $150 million in increased revenue potential.
  • The CRO industry is international. Its leading companies are familiar with regulatory procedures and business practices in a number of countries.